Hemosiderotic fibrolipomatous tumor D36.1

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Haemosiderotic fibrohistiocytic lipomatous tumour; Haemosiderotic fibrolipomatous tumour; Hemosiderotic fibrohistiocytic fibrolipomatous tumor; Hemosiderotic fibrohistiocytic lipomatous lesion

History
This section has been translated automatically.

Marshall-Taylor C et al. 2000

Definition
This section has been translated automatically.

Very rare, locally aggressively growing, postoperatively often recurrent (dignity?), but not metastasizing, mesenchymal tumor whose entity seems not yet consolidated. The demarcation to the "myxoinflammatory fibroblastic sarcoma" with common cytogenetic features is not yet clear

Manifestation
This section has been translated automatically.

Preferably infants, but also occurs in older age. Female persons seem to be more frequently affected.

Localization
This section has been translated automatically.

Back of hands and feet, lower extremity, occasionally also in the face.

Clinical features
This section has been translated automatically.

Uncharacteristic, 0.1-1.3 cm large (larger lesions also possible), subcutaneously localized, skin-colored or blue-atropical plaque, which may resemble an older hematoma. Nodules form less frequently.

Histology
This section has been translated automatically.

Colorful image with fascicles of fibroblastically differentiated, CD34-positive spindle cells (negative for smooth muscle actin and desmin) with injected islets of mature adipocytes, hemosiderin-storing macrophages and multinucleated, osteoclast-like giant cells. Mitoses are rare.

Therapy
This section has been translated automatically.

Operatively with sufficient (histologically safe) safety margin.

Literature
This section has been translated automatically.

  1. Browne TJ et al (2006) Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity. Histopathology 48:453-461.
  2. Hallor KH et al (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatoryfibroblastic
    sarcoma, haemosiderotic fibrolipomatous tumour, and morphologicallysimilar lesions. J path 217:716-727.
  3. Marshall-Taylor C et al(2000) Fibrohistiocytic lipoma: twelve cases of a previously undescribed benign fatty tumor. Ann Diagn Pathol 4:354-360.
  4. Marshall-Taylor C et al (2000) Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle. Mod Catholic 13:1192-1199.
  5. Sawalha S et al (2011) Recurrent haemosiderotic fibrohistiocytic lipomatous lesion of the hand. Malays J Pathol 33:43-45.
  6. West AT et al (2008) Haemosiderotic fibrohistiocytic lipomatous lesion/tumour of the foot: MRI and histopathology. Skeletal radiol 37:71-74.

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020